In 2005, a study published in Nature demonstrated that intranasal administration of oxytocin increases trust in humans. The research, led by Michael Kosfeld and colleagues, used a double-blind, placebo-controlled design to compare the trusting behavior of 58 participants (29 in the oxytocin group and 29 in the placebo group) in a trust game with real monetary stakes. The trust game involved two anonymous participants: an investor who could transfer money to a trustee, and a trustee who could decide how much of the increased funds to return to the investor. The study found that oxytocin significantly increased the amount of money investors were willing to transfer to trustees, with 45% of the oxytocin group transferring the maximum amount compared to 21% in the placebo group. This effect was not due to a general increase in risk-taking behavior, as investors showed no difference in risk decisions in a separate risk experiment where the outcome was determined by chance rather than the trustee's behavior. The results suggest that oxytocin specifically enhances trust in interpersonal interactions. The study also found that oxytocin did not affect the trustees' behavior, indicating that the effect is specific to the investors' trusting behavior. The findings support the hypothesis that oxytocin plays a key role in promoting prosocial behavior by facilitating social attachment and affiliation. The study highlights the biological basis of trust and its implications for social and economic interactions. The research has potential applications in understanding and treating social and mental health disorders.In 2005, a study published in Nature demonstrated that intranasal administration of oxytocin increases trust in humans. The research, led by Michael Kosfeld and colleagues, used a double-blind, placebo-controlled design to compare the trusting behavior of 58 participants (29 in the oxytocin group and 29 in the placebo group) in a trust game with real monetary stakes. The trust game involved two anonymous participants: an investor who could transfer money to a trustee, and a trustee who could decide how much of the increased funds to return to the investor. The study found that oxytocin significantly increased the amount of money investors were willing to transfer to trustees, with 45% of the oxytocin group transferring the maximum amount compared to 21% in the placebo group. This effect was not due to a general increase in risk-taking behavior, as investors showed no difference in risk decisions in a separate risk experiment where the outcome was determined by chance rather than the trustee's behavior. The results suggest that oxytocin specifically enhances trust in interpersonal interactions. The study also found that oxytocin did not affect the trustees' behavior, indicating that the effect is specific to the investors' trusting behavior. The findings support the hypothesis that oxytocin plays a key role in promoting prosocial behavior by facilitating social attachment and affiliation. The study highlights the biological basis of trust and its implications for social and economic interactions. The research has potential applications in understanding and treating social and mental health disorders.